European Pharmaceutical Review
APRIL 26, 2024
“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceutical company Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).
pharmaphorum
MARCH 10, 2022
Accordingly, pharmaceutical companies are expected to up their investment in this area, both in terms of production infrastructure and expertise.”. “This trend will continue in the near future with a steady increase in market demand over the coming years, alongside further development in cell and gene therapies,” says Magnelli.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 12, 2021
With an attractive corporate tax rate and the youngest workforce in the EU, Ireland continues to be a popular destination for life science companies to settle. Although cities such as Dublin and Cork were the traditional centres for pharmaceutical companies, a new wave of regional investment is happening across the country.
Pharmaceutical Technology
MAY 23, 2023
The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. While a handful of incentives are offered by the reform package, they are overshadowed by the potential drawbacks for the innovative sector.
The Checkup by Singlecare
APRIL 5, 2024
Pharmaceutical companies typically only provide prescription drug samples to healthcare providers, who keep them in the office for patients to use. Samples often come in a package of four 2.5 Keep in mind that a healthcare provider will only give you free samples if they think it would benefit your specific condition.
Expert insights. Personalized for you.
85 
Let's personalize your content